COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
October 2013

31

October
2013

category:

503b Compounding

Mass. Senate OKs compounding pharmacy regulation bill

The Senate today unanimously approved legislation regulating compounding pharmacies, nearly a year after a deadly national meningitis outbreak that originated at a Framingham pharmacy. The House approved its version of the bill earlier this month. Sen. John Keenan (D-Quincy), who co-chairs the Committee on Public Health, said the legislation brings compounding pharmacies “out of the […]

read more

31

October
2013

category:

503b Compounding

South Lyon Pharmacy Closes Doors After Contamination Discovered

10/31/13 – Specialty Medicine Compounding Pharmacy in South Lyon has closed its doors following the discovery of mold in some of its sterile medications. On October 16th, Henry Ford Hospital in Detroit identified vials of dextrose solution, known as D50, produced by the pharmacy that had strange particles in the fluid. The hospital analyzed numerous […]

read more

29

October
2013

category:

503b Compounding

H.R. 3204: Drug Quality and Security Act – 42% of Passage

Status This bill passed in the House on September 28, 2013 and goes to the Senate next for consideration. Progress Introduced Sep 27, 2013 Referred to Committee Sep 27, 2013 Passed House Sep 28, 2013 Passed Senate … Signed by the President … Prognosis 42% chance of being enacted. Only about 23% of bills that […]

read more